Clinical Trials Directory

Trials / Completed

CompletedNCT00304421

Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD

Comparison of the Nighttime Effects of Rabeprazole 20 mg to Pantoprazole 40 mg on Standard Meal Stimulated Gastric Acid Secretion and Intragastric pH in H. Pylori Negative Volunteer Subjects With GERD

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (estimated)
Sponsor
VA Greater Los Angeles Healthcare System · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to compare the effect of two different drugs, rabeprazole (20 mg) and pantoprazole (40 mg), and their effects on the amount of acid produced by your stomach on evening and at night after standard protein meal.

Detailed description

Gastric acid secretion can be divided into two phases: the daytime phase and the nocturnal phase. Nocturnal acid reflux is presumably more damaging because of loss of salivary neutralization. The present study is designed to measure effects of rabeprazole and pantoprazole on post-prandial and nocturnal gastric acid secretion and intragastric pH in H. pylori-negative volunteers with gastroesophageal reflux disease. These measurement will be used to compare the degree of inhibition of gastric acid secretion between the two drugs.

Conditions

Interventions

TypeNameDescription
DRUGrabeprazole
DRUGpantoprazole

Timeline

Start date
2004-01-01
Completion
2007-09-01
First posted
2006-03-17
Last updated
2007-09-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00304421. Inclusion in this directory is not an endorsement.

Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD (NCT00304421) · Clinical Trials Directory